What Happened?
Newark, NJ-based Rafael-Holdings Promoted Patrick Fabbio as President and Chief Financial Officer
About the Company
Rafael Holdings is focused on the development of novel cancer therapies. The company is a significant investor in two clinical stage oncology companies, Rafael Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd. Through its wholly owned Barer Institute subsidiary, the company is developing a pipeline of compounds focused on the regulation of cancer metabolism.
About the Person
Patrick Fabbio is President and Chief Financial Officer at Rafael Holdings. Previously, Patrick held various senior HR leadership roles in the industry.
Info Source
News
Short Profile